Amongst previously described anti-endothelial antibodies, those directed against the angiotensin II type 1 receptor (AT1R-Ab) are associated with essential hypertension [6], pre-eclampsia [7], and vascular rejection following renal transplant [8]. Here, AGTR1 is linked to hypertensive disorder.